位置:首页 > 蛋白库 > URE1_PROMH
URE1_PROMH
ID   URE1_PROMH              Reviewed;         567 AA.
AC   P17086; B4EXN5;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   20-JAN-2009, sequence version 2.
DT   03-AUG-2022, entry version 155.
DE   RecName: Full=Urease subunit alpha {ECO:0000255|HAMAP-Rule:MF_01953};
DE            EC=3.5.1.5 {ECO:0000255|HAMAP-Rule:MF_01953};
DE   AltName: Full=Urea amidohydrolase subunit alpha {ECO:0000255|HAMAP-Rule:MF_01953};
GN   Name=ureC {ECO:0000255|HAMAP-Rule:MF_01953}; OrderedLocusNames=PMI3685;
OS   Proteus mirabilis (strain HI4320).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Morganellaceae; Proteus.
OX   NCBI_TaxID=529507;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2687233; DOI=10.1128/jb.171.12.6414-6422.1989;
RA   Jones B.D., Mobley H.L.T.;
RT   "Proteus mirabilis urease: nucleotide sequence determination and comparison
RT   with jack bean urease.";
RL   J. Bacteriol. 171:6414-6422(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=HI4320;
RX   PubMed=18375554; DOI=10.1128/jb.01981-07;
RA   Pearson M.M., Sebaihia M., Churcher C., Quail M.A., Seshasayee A.S.,
RA   Luscombe N.M., Abdellah Z., Arrosmith C., Atkin B., Chillingworth T.,
RA   Hauser H., Jagels K., Moule S., Mungall K., Norbertczak H.,
RA   Rabbinowitsch E., Walker D., Whithead S., Thomson N.R., Rather P.N.,
RA   Parkhill J., Mobley H.L.T.;
RT   "Complete genome sequence of uropathogenic Proteus mirabilis, a master of
RT   both adherence and motility.";
RL   J. Bacteriol. 190:4027-4037(2008).
RN   [3]
RP   UREASE AS A VIRULENCE FACTOR.
RX   PubMed=2180821; DOI=10.1128/iai.58.4.1120-1123.1990;
RA   Jones B.D., Lockatell C.V., Johnson D.E., Warren J.W., Mobley H.L.T.;
RT   "Construction of a urease-negative mutant of Proteus mirabilis: analysis of
RT   virulence in a mouse model of ascending urinary tract infection.";
RL   Infect. Immun. 58:1120-1123(1990).
RN   [4]
RP   CATALYTIC ACTIVITY, AND MUTAGENESIS OF HIS-312; CYS-319; HIS-320; HIS-321;
RP   HIS-472; HIS-527 AND HIS-533.
RX   PubMed=8500894; DOI=10.1128/iai.61.6.2570-2577.1993;
RA   Sriwanthana B., Mobley H.L.T.;
RT   "Proteus mirabilis urease: histidine 320 of UreC is essential for urea
RT   hydrolysis and nickel ion binding within the native enzyme.";
RL   Infect. Immun. 61:2570-2577(1993).
RN   [5]
RP   INDUCTION.
RX   PubMed=7678244; DOI=10.1128/jb.175.2.465-473.1993;
RA   Nicholson E.B., Concaugh E.A., Foxall P.A., Island M.D., Mobley H.L.T.;
RT   "Proteus mirabilis urease: transcriptional regulation by UreR.";
RL   J. Bacteriol. 175:465-473(1993).
RN   [6]
RP   CATALYTIC ACTIVITY, AND MUTAGENESIS OF VAL-267; GLY-422; MET-489 AND
RP   ASP-537.
RX   PubMed=7559355; DOI=10.1128/jb.177.19.5653-5660.1995;
RA   Island M.D., Mobley H.L.T.;
RT   "Proteus mirabilis urease: operon fusion and linker insertion analysis of
RT   ure gene organization, regulation, and function.";
RL   J. Bacteriol. 177:5653-5660(1995).
RN   [7]
RP   INTERACTION WITH UREA AND URED.
RX   PubMed=11157956; DOI=10.1128/jb.183.4.1423-1433.2001;
RA   Heimer S.R., Mobley H.L.T.;
RT   "Interaction of Proteus mirabilis urease apoenzyme and accessory proteins
RT   identified with yeast two-hybrid technology.";
RL   J. Bacteriol. 183:1423-1433(2001).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 H(+) + H2O + urea = CO2 + 2 NH4(+); Xref=Rhea:RHEA:20557,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:16199,
CC         ChEBI:CHEBI:16526, ChEBI:CHEBI:28938; EC=3.5.1.5;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01953,
CC         ECO:0000269|PubMed:7559355, ECO:0000269|PubMed:8500894};
CC   -!- COFACTOR:
CC       Name=Ni cation; Xref=ChEBI:CHEBI:25516;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01953};
CC       Note=Binds 2 nickel ions per subunit. {ECO:0000255|HAMAP-
CC       Rule:MF_01953};
CC   -!- PATHWAY: Nitrogen metabolism; urea degradation; CO(2) and NH(3) from
CC       urea (urease route): step 1/1. {ECO:0000255|HAMAP-Rule:MF_01953}.
CC   -!- SUBUNIT: Probable heterotrimer of UreA (gamma), UreB (beta) and UreC
CC       (alpha) subunits. Three heterotrimers associate to form the active
CC       enzyme. The trimeric urease interacts with an accessory complex
CC       composed of UreD, UreF and UreG, which is required for the assembly of
CC       the nickel containing metallocenter of UreC. The UreE protein may also
CC       play a direct role in nickel transfer to the urease apoprotein.
CC       {ECO:0000269|PubMed:11157956}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_01953}.
CC   -!- INDUCTION: By urea. {ECO:0000269|PubMed:7678244}.
CC   -!- PTM: Carboxylation allows a single lysine to coordinate two nickel
CC       ions. {ECO:0000255|HAMAP-Rule:MF_01953}.
CC   -!- SIMILARITY: Belongs to the metallo-dependent hydrolases superfamily.
CC       Urease alpha subunit family. {ECO:0000255|HAMAP-Rule:MF_01953}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M31834; AAA25669.1; -; Genomic_DNA.
DR   EMBL; AM942759; CAR47185.1; -; Genomic_DNA.
DR   PIR; D43719; D43719.
DR   RefSeq; WP_004245262.1; NC_010554.1.
DR   AlphaFoldDB; P17086; -.
DR   SMR; P17086; -.
DR   STRING; 529507.PMI3685; -.
DR   MEROPS; M38.982; -.
DR   EnsemblBacteria; CAR47185; CAR47185; PMI3685.
DR   GeneID; 6801207; -.
DR   KEGG; pmr:PMI3685; -.
DR   eggNOG; COG0804; Bacteria.
DR   HOGENOM; CLU_000980_0_0_6; -.
DR   OMA; GFDSHIH; -.
DR   UniPathway; UPA00258; UER00370.
DR   Proteomes; UP000008319; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016151; F:nickel cation binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0009039; F:urease activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0043419; P:urea catabolic process; IEA:UniProtKB-UniPathway.
DR   CDD; cd00375; Urease_alpha; 1.
DR   Gene3D; 2.30.40.10; -; 1.
DR   HAMAP; MF_01953; Urease_alpha; 1.
DR   InterPro; IPR006680; Amidohydro-rel.
DR   InterPro; IPR011059; Metal-dep_hydrolase_composite.
DR   InterPro; IPR032466; Metal_Hydrolase.
DR   InterPro; IPR011612; Urease_alpha_N_dom.
DR   InterPro; IPR017950; Urease_AS.
DR   InterPro; IPR005848; Urease_asu.
DR   InterPro; IPR017951; Urease_asu_c.
DR   InterPro; IPR029754; Urease_Ni-bd.
DR   Pfam; PF01979; Amidohydro_1; 1.
DR   Pfam; PF00449; Urease_alpha; 1.
DR   PRINTS; PR01752; UREASE.
DR   SUPFAM; SSF51338; SSF51338; 2.
DR   SUPFAM; SSF51556; SSF51556; 1.
DR   TIGRFAMs; TIGR01792; urease_alph; 1.
DR   PROSITE; PS01120; UREASE_1; 1.
DR   PROSITE; PS00145; UREASE_2; 1.
DR   PROSITE; PS51368; UREASE_3; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Hydrolase; Metal-binding; Nickel; Reference proteome; Virulence.
FT   CHAIN           1..567
FT                   /note="Urease subunit alpha"
FT                   /id="PRO_0000067547"
FT   DOMAIN          129..567
FT                   /note="Urease"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01953"
FT   ACT_SITE        320
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000305"
FT   BINDING         134
FT                   /ligand="Ni(2+)"
FT                   /ligand_id="ChEBI:CHEBI:49786"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01953"
FT   BINDING         136
FT                   /ligand="Ni(2+)"
FT                   /ligand_id="ChEBI:CHEBI:49786"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01953"
FT   BINDING         217
FT                   /ligand="Ni(2+)"
FT                   /ligand_id="ChEBI:CHEBI:49786"
FT                   /ligand_label="1"
FT                   /note="via carbamate group"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01953"
FT   BINDING         217
FT                   /ligand="Ni(2+)"
FT                   /ligand_id="ChEBI:CHEBI:49786"
FT                   /ligand_label="2"
FT                   /note="via carbamate group"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01953"
FT   BINDING         219
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01953"
FT   BINDING         246
FT                   /ligand="Ni(2+)"
FT                   /ligand_id="ChEBI:CHEBI:49786"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01953"
FT   BINDING         272
FT                   /ligand="Ni(2+)"
FT                   /ligand_id="ChEBI:CHEBI:49786"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01953"
FT   BINDING         360
FT                   /ligand="Ni(2+)"
FT                   /ligand_id="ChEBI:CHEBI:49786"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01953"
FT   MOD_RES         217
FT                   /note="N6-carboxylysine"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01953"
FT   MUTAGEN         267
FT                   /note="V->VRRRI: Abrogates activity."
FT                   /evidence="ECO:0000269|PubMed:7559355"
FT   MUTAGEN         312
FT                   /note="H->L: Reduces activity 30-fold."
FT                   /evidence="ECO:0000269|PubMed:8500894"
FT   MUTAGEN         319
FT                   /note="C->A: Abrogates activity."
FT                   /evidence="ECO:0000269|PubMed:8500894"
FT   MUTAGEN         320
FT                   /note="H->L: Abrogates activity and reduces binding to
FT                   nickel ions."
FT                   /evidence="ECO:0000269|PubMed:8500894"
FT   MUTAGEN         321
FT                   /note="H->L: Abrogates activity."
FT                   /evidence="ECO:0000269|PubMed:8500894"
FT   MUTAGEN         422
FT                   /note="G->GSVDG: Abrogates activity."
FT                   /evidence="ECO:0000269|PubMed:7559355"
FT   MUTAGEN         472
FT                   /note="H->L: Reduces activity 12-fold."
FT                   /evidence="ECO:0000269|PubMed:8500894"
FT   MUTAGEN         489
FT                   /note="M->MRRRI: Abrogates activity."
FT                   /evidence="ECO:0000269|PubMed:7559355"
FT   MUTAGEN         527
FT                   /note="H->L: Reduces activity 6-fold."
FT                   /evidence="ECO:0000269|PubMed:8500894"
FT   MUTAGEN         533
FT                   /note="H->L: Reduces activity 300-fold."
FT                   /evidence="ECO:0000269|PubMed:8500894"
FT   MUTAGEN         537
FT                   /note="D->DRRRI: Reduces activity 25-fold."
FT                   /evidence="ECO:0000269|PubMed:7559355"
FT   CONFLICT        454
FT                   /note="A -> R (in Ref. 1; AAA25669)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   567 AA;  60927 MW;  E7747728624EC549 CRC64;
     MKTISRQAYA DMFGPTTGDR LRLADTELFL EIEKDFTTYG EEVKFGGGKV IRDGMGQSQV
     VSAECVDVLI TNAIILDYWG IVKADIGIKD GRIVGIGKAG NPDVQPNVDI VIGPGTEVVA
     GEGKIVTAGG IDTHIHFICP QQAQEGLVSG VTTFIGGGTG PVAGTNATTV TPGIWNMYRM
     LEAVDELPIN VGLFGKGCVS QPEAIREQIT AGAIGLKIHE DWGATPMAIH NCLNVADEMD
     VQVAIHSDTL NEGGFYEETV KAIAGRVIHV FHTEGAGGGH APDVIKSVGE PNILPASTNP
     TMPYTINTVD EHLDMLMVCH HLDPSIPEDV AFAESRIRRE TIAAEDILHD MGAISVMSSD
     SQAMGRVGEV ILRTWQCAHK MKLQRGTLAG DSADNDNNRI KRYIAKYTIN PALAHGIAHT
     VGSIEKGKLA DIVLWDPAFF GVKPALIIKG GMVAYAPMGD INAAIPTPQP VHYRPMYACL
     GKAKYQTSMI FMSKAGIEAG VPEKLGLKSL IGRVEGCRHI TKASMIHNNY VPHIELDPQT
     YIVKADGVPL VCEPATELPM AQRYFLF
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024